QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.107.036871v1 72/3/604    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Patana, A.-S. Articles by Finel, M. Search for Related Content PubMed PubMed Citation Articles by Patana, A.-S. Articles by Finel, M.

The Human UDP-Glucuronosyltransferase: Identification of Key Residues within the Nucleotide-Sugar Binding Site

Structural Biology and Biophysics, Institute of Biotechnology (A-S.P., A.G.); Drug Discovery and Development Technology Center (DDTC) and Division of Pharmaceutical Chemistry, Faculty of Pharmacy (M.K., M.F.), and Neuroscience Center (A.G.), University of Helsinki, Helsinki, Finland

UDP-glucuronosyltransferases (UGTs) play important roles in the metabolism, detoxification,and clearance of many different xenobiotics, including drugs and endogenous compounds. Structural information about these membrane-bound enzymes of the endoplasmic reticulum is limited. We do not know the identity or the location of the key residues for catalysis and binding of the aglycone substrate and the cosubstrate UDP-glucuronic acid (UDPGA). One suggestion was that His371 (UGT1A6 numbering) is the "catalytic base" that deprotonates the phenol group. We have now re-examined this hypothesis by analyzing the activities of the corresponding mutants, 6H371A (in UGT1A6) and the 9H369A (in UGT1A9). The K_m values of mutant 6H371A for scopoletin and UDPGA were higher by 4- and 11-fold, respectively, than in UGT1A6. The K_d for the enzyme-UDPGA complex, derived from bisubstrate kinetics, was about 9-fold higher in 6H371A than in UGT1A6, indicating severely impaired cosubstrate binding by the mutant. The effect of mutation on V_max was large in UGT1A6 but variable in UGT1A9, suggesting that His371 does not play the catalytic role previously hypothesized. In both UGTs, the E379A mutation (UGT1A6 numbering) had an effect similar to that of the H371A mutations. A homology model of the putative UDPGA binding region of UGT1A6 was built using distant homologous protein structures from the "GT1 class." The combined results of activity determinations, kinetic analyses, and modeling strongly suggest that His371 and Glu379 are directly involved in UDPGA binding but are not the general acid or general base.

Address correspondence to: Moshe Finel, DDTC, Faculty of Pharmacy, P.O. Box 56. University of Helsinki, FIN-00014, Finland. E-mail: moshe.finel{at}helsinki.fi

This article has been cited by other articles:

				P. I. Mackenzie, A. Rogers, J. Treloar, B. R. Jorgensen, J. O. Miners, and R. Meech Identification of UDP Glycosyltransferase 3A1 as a UDP N-Acetylglucosaminyltransferase J. Biol. Chem., December 26, 2008; 283(52): 36205 - 36210. [Abstract] [Full Text] [PDF]

				A.-S. Patana, M. Kurkela, M. Finel, and A. Goldman Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferases Protein Eng. Des. Sel., September 1, 2008; 21(9): 537 - 543. [Abstract] [Full Text] [PDF]

				Y. Xiong, A.-S. Patana, M. J. Miley, A. K. Zielinska, S. M. Bratton, G. P. Miller, A. Goldman, M. Finel, M. R. Redinbo, and A. Radominska-Pandya The First Aspartic Acid of the DQxD Motif for Human UDP-Glucuronosyltransferase 1A10 Interacts with UDP-Glucuronic Acid during Catalysis Drug Metab. Dispos., March 1, 2008; 36(3): 517 - 522. [Abstract] [Full Text] [PDF]